prof.dr. S. Siesling (Sabine)

Medicine & Life Sciences

# Breast Neoplasms
# Mastectomy
# Neoplasms
# Netherlands
# Population
# Recurrence
# Registries
# Survival

Faculty of Behavioural, Management and Social Sciences (BMS), Health Technology & Services Research (HTSR)

PALGA (Pathologische anatomisch geautomatiseerd archief)
lid Raad van Toezicht
IKNL
senior onderzoeker

Neven, A. , van Maaren, M. C., Schreuder, K., Kranse, R., Struikmans, H., Poortmans, P. M., Bartelink, H., Collette, L., Liu, L. , & Siesling, S. (2022). Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registry. Journal of clinical epidemiology, 148, 54-64. https://doi.org/10.1016/j.jclinepi.2022.04.014

Siesling, S. (2022). Oncologienetwerken in beeld.

van Deukeren, D., Heesterman, B. L., Roelofsk, L., Kiemeney, L. A., Witjes, J. A., Smilde, T. J., van Leenders, G. J. L. H., Incrocci, L., Vanneste, B. G. L., Meijer, R. P. , Siesling, S., van Bezooijen, B. P. J., & Aben, K. (2022). Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands. Cancer Treatment and Research Communications, 31, [100553]. https://doi.org/10.1016/j.ctarc.2022.100553

de Jong, V. M. T., Wang, Y., ter Hoeve, N. D., Opdam, M., Stathonikos, N., Jóźwiak, K., Hauptmann, M., Cornelissen, S., Vreuls, W., Rosenberg, E. H., Koop, E., Varga, Z., van Deurzen, C. H. M., Mooyaart, A. L., Cordoba, A., Groen, E. J., Bart, J., Willems, S. M., Zolota, V., ... Linn, S. C. (2022). Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy. Journal of clinical oncology. https://doi.org/10.1200/JCO.21.01536

Ankersmid, J. W., Spronk, P. E. R., Zeillemaker, A. M. , & Siesling, S. (2022). Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty. Breast cancer research and treatment, 193, 293-303. https://doi.org/10.1007/s10549-022-06549-9

Ploumen, R. A. W., Keymeulen, K. B. M. I., Kooreman, L. F. S., van Kuijk, S. M. J. , Siesling, S. , Smidt, M. L., & van Nijnatten, T. J. A. (2022). The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study. European journal of surgical oncology, 48(1), 60-66. https://doi.org/10.1016/j.ejso.2021.10.016

Bonenkamp, H., Habets, P. , & Siesling, S. (2022). Follow-up vereist maatwerk. Medische oncologie, 25(1).

Slotman, E., Schreuder, K., Nijsten, T. E. C., Wakkee, M., Hollestein, L. M., Mooyaart, A. , Siesling, S., & Louwman, M. W. (2022). The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays. Journal of the European Academy of Dermatology and Venereology, 36(5), 680-687. https://doi.org/10.1111/jdv.17976

Evers, J., Hendriks, L. E. L., De Jaeger, K., Wijsman, R., De Ruysscher, D., Terhaard, C., van der Sangen, M. , Siesling, S., Struikmans, H., & Aarts, M. J. (2022). Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011)). Lung cancer, 167, 107-107. https://doi.org/10.1016/j.lungcan.2021.12.012

Ankersmid, J. W. , Drossaert, S. C. H. C., van Riet, Y. E. A., Strobbe, L. J. A. , & Siesling, S. (2022). Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance. Journal of cancer survivorship. https://doi.org/10.1007/s11764-022-01178-z

Bekijk alle publicaties van deze medewerker

Vakken in het huidig collegejaar worden toegevoegd op het moment dat zij definitief zijn in het Osiris systeem. Daarom kan het zijn dat de lijst nog niet compleet is voor het gehele collegejaar.